Skip to main content Skip to main navigation menu Skip to site footer

Current Issue

Vol 16 No 34 (2026): Journal of Jembut
Published: 2026-08-01

Full Issue

View All Issues

Research

Clinical evidence to support the role of leptin in the mediation of hyperthytropinemia of obesity | Senses and Sciences
Skip to main content Skip to main navigation menu Skip to site footer

Clinical evidence to support the role of leptin in the mediation of hyperthytropinemia of obesity

  • Amira Mostafa Roshdy Endocrinology department, Alexandria Faculty of Medicine, Egypt
  • Aliaa Aly El-Aghoury
  • Ola Atef Sharaki
  • Tamer Mohamed El-Sherbiny
Keywords: Obesity, leptin, TSH

Abstract

Background: Obesity is a common health problem. In obesity, thyrotropin (TSH) levels are at the upper limit of the normal range or slightly elevated and positively correlated with body mass index. Leptin resistance and hyperleptinemia is also common in obesity.

Material & Method: This was a cross-section study of 80 subjects grouped into 2 groups; obese euthyroid subjects with BMI more than 35 (n = 40) and normal subjects with normal BMI (n = 40). TSH, Free T4, and Leptin were measured and anthropometric measures were taken.

Results: TSH was significantly higher in obese subjects versus the control (mean ± SD 2.04 ± 1.51 µIU/mL vs1.46 ± 0.96 µIU/mL, p = 0.024).

Conclusion: These results lead us to confirm that leptin level has an important role in the link between hyperthyrotropinemia and obesity.

Published
2022-11-04